LG CNS (064400.KS) will deploy artificial intelligence agents across operations at the Chaum health screening center. After a proof-of-concept test at Chaum, the company plans to expand the technology to major screening centers run by CHA Hospital.
LG CNS said on the 9th that it held a kickoff meeting with Chaum and CHA Healthcare on introducing an intelligent screening center at the Chaum health screening center in Seoul's Gangnam district. Under the partnership, LG CNS will develop AI agents tailored to screening operations, and Chaum will apply them in actual screening settings to verify efficiency gains and potential uses.
The move follows LG CNS's strategic investment in CHA Bio Group in January this year. Starting with this partnership, the company plans to build out an AI-based health screening business and later extend it to major CHA Hospital screening centers.
The AI agents under development focus on reducing repetitive data lookups and record-keeping by nurses during screenings. The Chaum center designs customized test packages based on each client's past screening history, consultation records and physician recommendations. Until now, nurses had to search multiple systems for the data themselves and handle consultation records, follow-up care and scheduling manually.
The AI agents will analyze past screening histories, test reports, consultation records and follow-up schedules scattered across customer relationship management and electronic medical record systems. Based on that analysis, they will also draft documents laying out which tests are needed and why.
The agents will also be used at the stage of delivering results. They will help draft result reports by combining test findings and diagnostic opinions, and manage schedules for retests and follow-up observation at three-, six- and nine-month intervals. They are also expected to be used to connect patients with abnormal findings to outpatient care, guide them through follow-up programs, and prepare pre-screening checklists of precautions for each client.
Chaum is also reviewing the use of AI interpretation and translation for foreign clients. Foreign nationals currently account for about 30% of all clients at the Chaum health screening center. The plan is to lower language barriers by applying AI-based interpretation and translation when explaining screening results and during consultations.
"We will apply the AX capabilities we have built up to medical settings to drive innovation in screening services and improve operational efficiency," Bae Min, executive vice president of LG CNS's finance and public sector division, said. Kim Jae-hwa, director of Chaum, said, "We will successfully establish an AI-based intelligent screening system at Chaum and set a new standard for premium health screening."
